PlainRecalls
FDA Drug Low Class III Terminated

Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-285-37

Reported: April 18, 2018 Initiated: March 5, 2018 #D-0698-2018

Product Description

Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-285-37

Reason for Recall

Failed impurities/degradation specifications: Failure to water content and impurity

Details

Units Affected
3222 vials
Distribution
U.S.A. nationwide
Location
Central Islip, NY

Frequently Asked Questions

What product was recalled?
Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-285-37. Recalled by InvaGen Pharmaceuticals, Inc.. Units affected: 3222 vials.
Why was this product recalled?
Failed impurities/degradation specifications: Failure to water content and impurity
Which agency issued this recall?
This recall was issued by the FDA Drug on April 18, 2018. Severity: Low. Recall number: D-0698-2018.